Does Dr. Farnen study Hodgkin's disease?

Yes, Dr. Farnen specifically studies the complications and metabolic effects associated with Hodgkin's disease.

What treatments has Dr. Farnen researched?

He has researched chemotherapy's impact on Hodgkin's disease and how it can alleviate symptoms related to low blood sugar.

Is Dr. Farnen's work relevant to patients with low blood sugar?

Yes, his findings about hypoglycemia linked to Hodgkin's disease are valuable for patients experiencing similar symptoms.

JOHN P. FARNEN, MD

LA CROSSE, WI

Research Active

Internal Medicine - Hematology & Oncology NPI registered 21+ years 2 publications 2006 – 2016 NPI: 1467457432

Internal Medicine - Hematology & Oncology

Antineoplastic Combined Chemotherapy ProtocolsC-PeptideAutoantibodiesDoxorubicinHodgkin DiseaseBleomycinHypothermiaHypoglycemiaMissouriConservation of Energy ResourcesCatholicismHospital Design and ConstructionHospitals, ReligiousOrganizational Case StudiesDacarbazine

Practice Location

1836 SOUTH AVE
LA CROSSE, WI 54601-5429

Phone: (608) 782-7300

What does JOHN FARNEN research?

Dr. Farnen focuses on the relationship between Hodgkin's disease and metabolic issues, especially low blood sugar episodes known as hypoglycemia. He studies how certain cancers, like Hodgkin's, can trigger abnormal hormone production that leads to these dangerous fluctuations in blood sugar. One notable case he examined involved a 60-year-old woman whose blood sugar dropped to critical levels, a complication that can cause confusion, fainting, or even seizures. By examining such cases, he aims to enhance the understanding of these rare but serious complications among patients with Hodgkin's disease.

Key findings

In a case study, a patient with Hodgkin's disease had blood glucose levels drop to as low as 32 mg/dL due to a cancer-related hormone abnormality.
After chemotherapy, the patient’s symptoms of fatigue and anemia improved significantly, and blood sugar levels normalized.
This research helps elucidate how Hodgkin's disease can lead to complications like hypoglycemia, enhancing care for affected patients.

Frequently asked questions

Does Dr. Farnen study Hodgkin's disease?: Yes, Dr. Farnen specifically studies the complications and metabolic effects associated with Hodgkin's disease.
What treatments has Dr. Farnen researched?: He has researched chemotherapy's impact on Hodgkin's disease and how it can alleviate symptoms related to low blood sugar.
Is Dr. Farnen's work relevant to patients with low blood sugar?: Yes, his findings about hypoglycemia linked to Hodgkin's disease are valuable for patients experiencing similar symptoms.

Publications in plain English

Rebuilding Mercy Hospital Joplin.

2016

Health progress (Saint Louis, Mo.)

Farnen J

PubMed

Recurrent hypoglycemia and hypothermia in a patient with Hodgkin's disease.

2006

Haematologica

Kulkarni A, Zlabek J, Farnen J, Capla R

Plain English
A 60-year-old woman with Hodgkin's disease experienced severe fatigue, anemia, and episodes of low blood sugar, with glucose levels dropping to as low as 32 mg/dL. After receiving chemotherapy, her symptoms disappeared, and her blood sugar levels stabilized, indicating that the cancer was likely producing a substance similar to insulin that caused her hypoglycemia. This finding is significant because it links a rare complication of Hodgkin's disease to an abnormal insulin-like substance, which can improve understanding and treatment for similar cases. Who this helps: This helps patients with Hodgkin’s disease and their doctors by providing insight into potential complications.

PubMed

Frequent Co-Authors

Amit Kulkarni Jonathan Zlabek Robert Capla

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.